Related Experiment Video
Updated: Oct 7, 2026

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
Published on: August 12, 2015
BRD2 impedes iPSC reprogramming by regulating lipid biosynthesis and the matrisome via its ET tail
Ricardo Raul Cevallos1,2, Ruowen Zhang2,3, Rajpal Sian4
1Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, USA.
Abstract:
Induction of human pluripotent stem cells (hiPSCs) from somatic cells encounters significant barriers that remain poorly understood. Lipids are fundamental cellular molecules with many essential roles. However, the roles of lipids in reprogramming are unknown. Here, we show that BRD2 is a barrier to hiPSC reprogramming by suppressing lipid genes and maintaining the somatic transcriptional program, particularly the somatic matrisome program. Strikingly, the acetylation epigenetic reader BRD2 unorthodoxly suppresses the expression of lipid-related genes in the reprogramming cells. The two rate-limiting enzymes of lipid biosynthesis, stearoyl-CoA desaturase (SCD), 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase (HMGCR), and lipid supplements all enhance iPSC reprogramming. Interestingly, the extra terminal (ET) tail of BRD2 suppresses reprogramming and the lipid transcriptional program but positively regulates the matrisome program. In line with its transcriptional suppression of lipid genes, BRD2 binds to genes of lipid biosynthesis and negatively regulates their H3K27Ac status. These discoveries advance our molecular understanding of hiPSC reprogramming, as well as of the transcriptional regulation of matrisome and lipid programs.
Related Concept Videos
Negative Regulator Molecules
Regulation of the Unfolded Protein Response
Riboswitches
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
Experimental RNAi
Regulation of Nuclear Protein Sorting
Long-patch Base Excision Repair
